ATLANTA (PRWEB) April 16, 2015
ATLANTA – April 15, 2015 – Greenberg Traurig, LLP’s Lori G. Cohen will speak at the American Conference Institute’s (ACI) Women Leaders in EU Life Sciences Law Conference taking place April 22-23, 2015 in Munich, Germany.
The conference is designed to empower women in the life sciences legal community and to give women the skills necessary for continued success. It provides an opportunity to network with and engage in candid discussion with leaders from biopharmaceutical and medical device companies. Cohen will speak April 22, 2015, at 11:30 a.m. on a panel entitled “Advancing in the Life Sciences Legal Community: Overcoming Implicit Gender Bias and Creating and Sustaining a Robust Network.” The conference immediately follows ACI's Summit on U.S. Biosimilars April 20-21, 2015, also in Munich.
The Women Leaders in EU Life Sciences Law Conference is a companion event to ACI’s Women Leaders in Life Sciences Law Conference, which takes place in Boston from July 23-24, 2015. Greenberg Traurig is a sponsor of the U.S. event, now in its second year, and Cohen will again co-chair it.
Cohen is chair of Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice and Trial Practice. She has a national litigation practice focusing on product liability litigation and specifically, medical device and pharmaceutical litigation. She is widely recognized for her trial skills, having received 56 defense verdicts at trial. She was profiled in Law360’s 2012 "Top Female Trial Attorneys," The Financial Times, and The National Law Journal’s “Winning - Successful Strategies From Some of the Nation’s Top Litigators,” a special report recognizing 10 attorneys from across the United States. The National Law Journal recognized Cohen as one of "The 50 Most Influential Women Lawyers in America” and recognized two of her defense trial victories as “Top Defense Wins” in recent years. Cohen has also been recognized by Georgia Super Lawyers magazine as one of its "Top 10 Georgia Super Lawyers" for the last three years, and one of the "Top 100 Georgia Super Lawyers" and "Top 50 Female Georgia Super Lawyers" for the last 11 years. In addition, she is one of a very small group of attorneys selected nationally for inclusion in the 2010-2014 editions of Chambers and Partners USA Guide's national Pharmaceutical Industry Products Liability Table.
About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice
The Pharmaceutical, Medical Device & Health Care Litigation Practice is an integral part of the firm’s 600-plus member national Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include national rankings for 2014 “Products Liability & Mass Torts” from Chambers USA Guide; national rankings for 2014 “Practice Liability & Mass Torts Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States; and a first-tier national ranking for "Litigation – Mass Tort Litigation and Class Actions – Defendants" from U.S. News – Best Lawyers® 2015 Best Law Firms. In addition, Greenberg Traurig is recognized as a "Product Liability Litigation Standout" in the BTI Litigation Outlook 2015 published by BTI Consulting Group.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1,800 attorneys serving clients from 37 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is among the “Power Elite” in the 2014 BTI Client Relationship Scorecard report, which assesses the nature and strength of law firms' client relationships. For additional information, please visit http://www.gtlaw.com.